Found: 45
Select item for more details and to access through your institution.
Radiomics of cholangiocarcinoma on pretreatment CT can identify patients who would best respond to radioembolisation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Research and Clinical Landscape of Bispecific Antibodies for the Treatment of Solid Malignancies.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 9, p. 884, doi. 10.3390/ph14090884
- By:
- Publication type:
- Article
Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better?
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 1, p. 21, doi. 10.1007/s11912-023-01487-1
- By:
- Publication type:
- Article
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan.
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 12, p. 1467, doi. 10.1007/s11912-023-01469-3
- By:
- Publication type:
- Article
Bystander effect of antibody–drug conjugates: fact or fiction?
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 7, p. 809, doi. 10.1007/s11912-022-01266-4
- By:
- Publication type:
- Article
Activity of novel anti-HER2 agents for breast cancer based on hormone receptors expression.
- Published in:
- 2021
- By:
- Publication type:
- Letter
New anti-HER2 agents for brain metastasis: histology-agnostic weapons?
- Published in:
- 2021
- By:
- Publication type:
- Letter
The HER2-low revolution in breast oncology: steps forward and emerging challenges.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231152842
- By:
- Publication type:
- Article
Emerging Targeted Therapies for Early Breast Cancer.
- Published in:
- Drugs, 2022, v. 82, n. 14, p. 1437, doi. 10.1007/s40265-022-01781-5
- By:
- Publication type:
- Article
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43324-w
- By:
- Publication type:
- Article
Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43324-w
- By:
- Publication type:
- Article
ASCO 2024: Personal Insights and a Look into the Future from an International Expert Group.
- Published in:
- 2024
- By:
- Publication type:
- Proceeding
CONTINUING MEDICAL EDUCATION (CME). Emerging Treatments and Evolving Paradigms in HER2-Low Breast Cancer.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 12, p. 496
- By:
- Publication type:
- Article
Paolo Tarantino, MD, Spotlights Treatment Trends for Breast Cancer Awareness Month.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 10, p. 592
- By:
- Publication type:
- Article
EGFR-TKI Plus Anti-Angiogenic Drugs in EGFR-Mutated Non–Small Cell Lung Cancer: A Meta-Analysis of Randomized Clinical Trials.
- Published in:
- JNCI Cancer Spectrum, 2020, v. 4, n. 6, p. 1, doi. 10.1093/jncics/pkaa064
- By:
- Publication type:
- Article
Immunotherapy for early triple negative breast cancer: research agenda for the next decade.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00386-1
- By:
- Publication type:
- Article
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00385-2
- By:
- Publication type:
- Article
Filling the Gap after CDK4/6 Inhibitors: Novel Endocrine and Biologic Treatment Options for Metastatic Hormone Receptor Positive Breast Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 2015, doi. 10.3390/cancers15072015
- By:
- Publication type:
- Article
Resistance to Antibody-Drug Conjugates Targeting HER2 in Breast Cancer: Molecular Landscape and Future Challenges.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1130, doi. 10.3390/cancers15041130
- By:
- Publication type:
- Article
Overcoming Resistance to HER2-Directed Therapies in Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 3996, doi. 10.3390/cancers14163996
- By:
- Publication type:
- Article
Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor Boards.
- Published in:
- Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133193
- By:
- Publication type:
- Article
Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical Trials.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5829, doi. 10.3390/cancers13225829
- By:
- Publication type:
- Article
Spectrum of Germline Pathogenic Variants in BRCA1/2 Genes in the Apulian Southern Italy Population: Geographic Distribution and Evidence for Targeted Genetic Testing.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4714, doi. 10.3390/cancers13184714
- By:
- Publication type:
- Article
Lessons From Recent Trials of Antibody-Drug Conjugates in Breast Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2022, v. 20, n. 12, p. 719
- By:
- Publication type:
- Article
Systemic Treatment of Ductal Carcinoma In Situ of the Breast.
- Published in:
- Chirurgia, 2021, v. 116, p. S97, doi. 10.21614/chirurgia.116.5.suppl.s97
- By:
- Publication type:
- Article
HER2-Low Breast Cancer: a New Subtype?
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 5, p. 468, doi. 10.1007/s11864-023-01068-1
- By:
- Publication type:
- Article
Enhancing Breast Cancer Risk Prediction with Machine Learning: Integrating BMI, Smoking Habits, Hormonal Dynamics, and BRCA Gene Mutations—A Game-Changer Compared to Traditional Statistical Models?
- Published in:
- Applied Sciences (2076-3417), 2024, v. 14, n. 18, p. 8474, doi. 10.3390/app14188474
- By:
- Publication type:
- Article
CIRSE Standards of Practice on Thermal Ablation of Liver Tumours.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Monitoring of Thermal-Induced Changes in Liver Stiffness During Controlled Hyperthermia and Microwave Ablation in an Ex Vivo Bovine Model Using Point Shear Wave Elastography.
- Published in:
- CardioVascular & Interventional Radiology, 2019, v. 42, n. 5, p. 744, doi. 10.1007/s00270-018-02152-y
- By:
- Publication type:
- Article
Monitoring of Thermal-Induced Changes in Liver Stiffness During Controlled Hyperthermia and Microwave Ablation in an Ex Vivo Bovine Model Using Point Shear Wave Elastography.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Tailoring the Treatment of Early-stage HER2-positive Breast Cancer: One Size Does Not Fit All.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 1, p. 11, doi. 10.17925/OHR.2023.19.1.11
- By:
- Publication type:
- Article
Treatment of a hemorrhage secondary to nephrostomy tube placement for derivation of monstrous hydronephrosis in upper tract urothelial carcinoma.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
A new germline stop codon mutation in exon 15 of the APC gene predisposing to familial adenomatous polyposis.
- Published in:
- International Journal of Biological Markers, 2013, v. 28, n. 4, p. e405, doi. 10.5301/JBM.5000042
- By:
- Publication type:
- Article
The radiologist's role in detecting systemic anticancer therapy-related interstitial lung disease: an educational review.
- Published in:
- Insights into Imaging, 2024, v. 15, n. 1, p. 1, doi. 10.1186/s13244-024-01771-z
- By:
- Publication type:
- Article
Autoimmune Liver Diseases and Antiphospholipid Antibodies Positivity: a Meta-analysis of Literature Studies.
- Published in:
- Journal of Gastrointestinal & Liver Diseases, 2015, v. 24, n. 1, p. 25, doi. 10.15403/jgld.2014.1121.amb
- By:
- Publication type:
- Article
Prognosis and treatment outcomes for patients with stage IA triple-negative breast cancer.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00634-6
- By:
- Publication type:
- Article
Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National Experience.
- Published in:
- Oncologist, 2024, v. 29, n. 2, p. 159, doi. 10.1093/oncolo/oyad229
- By:
- Publication type:
- Article
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents.
- Published in:
- Oncologist, 2024, v. 29, n. 1, p. 75, doi. 10.1093/oncolo/oyad212
- By:
- Publication type:
- Article
Nodal positivity and systemic therapy among patients with clinical T1–T2N0 human epidermal growth factor receptor‐positive breast cancer: Results from two international cohorts.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1836, doi. 10.1002/cncr.34750
- By:
- Publication type:
- Article
The American Society of Clinical Oncology--College of American Pathologists Guideline Update for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: How Low Can HER2 Go?
- Published in:
- Archives of Pathology & Laboratory Medicine, 2023, v. 147, n. 9, p. 991, doi. 10.5858/arpa.2023-0187-ED
- By:
- Publication type:
- Article
Exploring a Novel Approach to Spare Classic Chemotherapy in HER2-Low, ER-Positive Breast Cancer Based on Trastuzumab Deruxtecan Combined with Endocrine Therapy.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies.
- Published in:
- CA: A Cancer Journal for Clinicians, 2022, v. 72, n. 2, p. 165, doi. 10.3322/caac.21705
- By:
- Publication type:
- Article
Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14–13/PrE0109).
- Published in:
- Breast Cancer Research, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13058-024-01899-2
- By:
- Publication type:
- Article
Sequencing Antibody Drug Conjugates in Breast Cancer: Exploring Future Roles.
- Published in:
- Current Oncology, 2023, v. 30, n. 12, p. 10211, doi. 10.3390/curroncol30120743
- By:
- Publication type:
- Article